[PDF][PDF] Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection
SKY Chang, WW Hlaing, RQ Yu, TWV Lee… - Singapore medical …, 2012 - researchgate.net
RESUlTS Out of the 72 patients, 34 (47.2%) suffered from HCC recurrence. 65.4% of
recurrent cases had AFP values showing an upward trend. Patients with recurrence had …
recurrent cases had AFP values showing an upward trend. Patients with recurrence had …
[PDF][PDF] The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma
R Gómez-Rodríguez, M Romero-Gutiérrez… - Revista Espanola de …, 2012 - Citeseer
Introduction and objectives: presently, the reference staging system to evaluate the
prognosis of hepatocellular carcinoma (HCC) patients is “The Barcelona Clinic Liver …
prognosis of hepatocellular carcinoma (HCC) patients is “The Barcelona Clinic Liver …
The significance of gamma-glutamyl transpeptidase to lymphocyte count ratio in the early postoperative recurrence monitoring and prognosis prediction of AFP …
Background Currently, there is still a lack of effective biomarkers for the recurrence
monitoring and survival prognosis assessment of hepatocellular carcinoma (HCC) patients …
monitoring and survival prognosis assessment of hepatocellular carcinoma (HCC) patients …
[HTML][HTML] The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma
DS Bai, C Zhang, P Chen, SJ Jin, GQ Jiang - Scientific reports, 2017 - nature.com
The purpose of this study was to conduct a comprehensive study of the clinical correlation
between the alpha-fetoprotein (AFP) level at diagnosis and pathological grades …
between the alpha-fetoprotein (AFP) level at diagnosis and pathological grades …
Pre‐transplant alpha‐fetoprotein is associated with post‐transplant hepatocellular carcinoma recurrence mortality
Background Although liver transplantation may potentially cure hepatocellular carcinoma
(HCC), the risk of HCC recurrence is 8%‐20% at five years post‐transplant. Pre‐transplant …
(HCC), the risk of HCC recurrence is 8%‐20% at five years post‐transplant. Pre‐transplant …
[HTML][HTML] Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma
M Yao, J Zhao, F Lu - Oncotarget, 2016 - ncbi.nlm.nih.gov
Use of serum alpha-fetoprotein (AFP) in clinical practices has been challenged in recent
years, due to the lack of specificity and sensitivity. Here we conducted a retrospective study …
years, due to the lack of specificity and sensitivity. Here we conducted a retrospective study …
Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical resection
Background & Aims In early-stage hepatocellular carcinoma (eHCC), radiofrequency
ablation (RFA) has comparable outcomes to surgical resection (SR); however …
ablation (RFA) has comparable outcomes to surgical resection (SR); however …
Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative …
MD Wang, LY Sun, GJ Qian, C Li, LH Gu… - International Journal of …, 2022 - Elsevier
Background Alpha-fetoprotein (AFP) and prothrombin induced by vitamin K absence-II
(PIVKA-II) are two commonly used biomarkers for detection and prognostic prediction of …
(PIVKA-II) are two commonly used biomarkers for detection and prognostic prediction of …